Trial intelligence / Profile preview

Effect of levosimendan on systolic deformation and diastolic function in patients with severe aortic stenosis undergoing valve replacement

2010-018490-38Phase 4Terminated

Sponsor
Aarhus University Hospital
Start
May 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of levosimendan in aortic stenosis (AS) and left ventricular hypertrophy (LVH), sponsored by Aarhus University Hospital. Started May 2010; status: terminated.

02

Drugs

levosimendan
03

Conditions

aortic stenosis (AS)left ventricular hypertrophy (LVH)

Beyond the preview

Go deeper on 2010-018490-38.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2010-018490-38.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call